Cargando…
SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus
An outbreak of the novel coronavirus SARS-CoV-2, the causative agent of Coronavirus Disease-2019 (COVID-19), a respiratory disease, has infected almost one hundred million people since the end of 2019, killed over two million, and caused worldwide social and economic disruption. Because the mechanis...
Autores principales: | Chen, Jungang, Dai, Lu, Barrett, Lindsey, James, Jennifer, Plaisance-Bonstaff, Karlie, Post, Steven R., Qin, Zhiqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175744/ https://www.ncbi.nlm.nih.gov/pubmed/34083759 http://dx.doi.org/10.1038/s42003-021-02220-z |
Ejemplares similares
-
Role of Interleukin-1 Family Members and Signaling Pathways in KSHV Pathogenesis
por: Barrett, Lindsey, et al.
Publicado: (2020) -
Oral Shedding of an Oncogenic Virus Alters the Oral Microbiome in HIV+ Patients
por: Dai, Lu, et al.
Publicado: (2022) -
Activation of IL1 signaling molecules by Kaposi’s sarcoma-associated herpesvirus
por: Chen, Jungang, et al.
Publicado: (2022) -
Role of Histamine and Related Signaling in Kaposi’s Sarcoma-Associated Herpesvirus Pathogenesis and Oncogenesis
por: Chen, Jungang, et al.
Publicado: (2023) -
Echinomycin as a promising therapeutic agent against KSHV-related malignancies
por: Chen, Jungang, et al.
Publicado: (2023)